Biospring Partners

Portfolio Companies 2026 for Biospring Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Biospring Partners accounts for 3 tracked companies with verified cap-table data, 3 of which disclose round sizes totalling $197M. The median disclosed raise is $65M, and the largest is Ncardia at $77M, ahead of Abzena plc ($65M) and Labviva ($55M).

The names that recur most often on these portfolio cap tables are Biospring Partners (3 companies), Welsh, Carson, Anderson & Stowe (2 companies), Kiniciti (1 company), Senator Investment Group (1 company), B Capital Group (1 company), Glasswing Ventures (1 company). By latest disclosed round, the market skews Growth (2), Series B (1).

Best funded Biospring Partners companies

  1. Ncardia — $77M (latest: Growth)
  2. Abzena plc — $65M (latest: Growth)
  3. Labviva — $55M (latest: Series B)

Biospring Partners — related firms and companies (46)

Biospring Partners alternatives · All research reports